SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-026650
Filing Date
2022-05-16
Accepted
2022-05-16 06:39:57
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_180lifesciences.htm   iXBRL 10-Q 663668
2 CERTIFICATION f10q0322ex31-1_180lifescie.htm EX-31.1 14873
3 CERTIFICATION f10q0322ex31-2_180lifescie.htm EX-31.2 13733
4 CERTIFICATION f10q0322ex32-1_180lifescie.htm EX-32.1 4833
5 CERTIFICATION f10q0322ex32-2_180lifescie.htm EX-32.2 4448
6 GRAPHIC image_001.jpg GRAPHIC 7744
  Complete submission text file 0001213900-22-026650.txt   4408973

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20220331.xsd EX-101.SCH 65401
8 XBRL CALCULATION FILE atnf-20220331_cal.xml EX-101.CAL 28947
9 XBRL DEFINITION FILE atnf-20220331_def.xml EX-101.DEF 229493
10 XBRL LABEL FILE atnf-20220331_lab.xml EX-101.LAB 500238
11 XBRL PRESENTATION FILE atnf-20220331_pre.xml EX-101.PRE 246733
59 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_180lifesciences_htm.xml XML 463387
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 22925327
SIC: 2834 Pharmaceutical Preparations